SPX3,783.28-7.65 -0.20%
DIA302.79-0.35 -0.12%
IXIC11,148.64-27.77 -0.25%

Evercore ISI Upgrades Akero Therapeutics to Outperform From In-Line, Adjusts Price Target to $50 From $10

Evercore ISI Upgrades Akero Therapeutics to Outperform From In-Line, Adjusts Price Target to $50 From $10

MT Newswires · 09/14/2022 01:02

Please log in to view news